Less Ads, More Data, More Tools Register for FREE

Pin to quick picksACRL.L Regulatory News (ACRL)

  • There is currently no data for ACRL

Completion of Acquisition

25 Nov 2020 07:00

RNS Number : 3909G
Accrol Group Holdings PLC
25 November 2020
 

25 November 2020

 

Accrol Group Holdings plc

("Accrol" or the "Company")

AIM: ACRL

 

Completion of the acquisition of Leicester Tissue Company Limited

 

Following the announcement made by the Company on the 23 November 2020 titled "Admission of Shares & Total Voting Rights" ("Announcement"), Accrol Group Holdings plc, a leading independent tissue converter in the UK, is pleased to announce that the Final Condition has now been satisfied and the Acquisition has now completed.

 

The capitalised terms used in this announcement have the same meanings as in the Announcement, unless otherwise stated.

 

Dan Wright, Executive Chairman of Accrol, said:

 

"We are delighted to announce the completion of this, our first acquisition. LTC fulfils all our selective M&A criteria. It's well-invested; it's ideally located, in central England; it has strong day-to-day management team; and its product mix and customer base are highly complementary to our existing business.

 

"The acquisition is immediately earnings enhancing and takes our share of the £1.7bn UK tissue market to c.16%. Importantly, it represents another milestone on our journey to build a world-class, operationally efficient business of size and scale, which delivers substantial returns to shareholders through organic and acquisitive growth. I would like to thank our existing and new shareholders for their support and confidence in our team and look forward to updating everyone on the progress of the integration in due course.

 

"On behalf of the team at Accrol, I welcome everyone at LTC to the Group and look forward to an exciting future working together."

 

For further information, please contact:

Accrol Group Holdings plc

Dan Wright, Executive Chairman

Via Belvedere Communications

Gareth Jenkins, Chief Executive Officer

Zeus Capital Limited (Nominated Adviser & Broker) 

Dan Bate / Jordan Warburton

Tel: +44 (0) 161 831 1512

Dominic King / John Goold

Tel: +44 (0) 203 829 5000

Liberum Capital Limited (Joint Broker)

Tel: +44 (0) 20 3100 2222

Clayton Bush / Edward Thomas

Deloitte LLP (Financial Adviser)

Tel: +44 (0) 20 7936 3000

Andrew Westbrook / Chris Nicholls

Belvedere Communications Limited

Cat Valentine

Tel: +44 (0) 7715 769 078

Keeley Clarke

Tel: +44 (0) 7967 816 525

Llew Angus

Tel: +44 (0) 7407 023 147

accrolpr@belvederepr.com

 

Notes to Editors

Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet tissues, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK. The business operates from four sites in Lancashire:

 

·

A manufacturing, storage, and distribution facility in Blackburn;

·

A storage and administrative centre in Blackburn;

·

A facial tissue plant, also in Blackburn; and

·

A manufacturing, storage, and distribution facility in Leyland.

 

For more information, please visit www.accrol.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQFEAFALESSEDF
Date   Source Headline
28th May 20247:00 amRNSCancellation - Accrol Group Holdings plc
24th May 20243:30 pmRNSForm 8.3 - ACRL LN
24th May 202411:29 amRNSEffective Scheme of Arrangement
24th May 20247:30 amRNSSuspension - Accrol Group Holdings plc
23rd May 20244:20 pmRNSTR-1
22nd May 20245:10 pmRNSForm 8.3 - Replacement ACCROL GROUP HOLDINGS PLC
22nd May 20243:30 pmRNSForm 8.3 - ACRL LN
22nd May 20243:19 pmRNSForm 8.3 - ACCROL GROUP HOLDINGS PLC
22nd May 20241:06 pmRNSCourt Sanction of Scheme Arrangement
20th May 20242:57 pmRNSForm 8.3 - Accrol Group Holdings PLC
20th May 20242:00 pmPRNForm 8.3 - Accrol Group Holdings Plc
17th May 20243:25 pmRNSForm 8.3 - ACCROL GROUP HOLDINGS PLC
17th May 20242:56 pmRNSForm 8.3 - ACCROL GROUP HOLDINGS PLC
17th May 202412:51 pmPRNForm 8.3 - Accrol Group Holdings plc
17th May 20248:12 amGNWForm 8.5 (EPT/RI) - Accrol Group Holdings Plc
16th May 20243:25 pmRNSForm 8.3 - ACCROL GROUP HOLDINGS PLC
16th May 202412:24 pmPRNForm 8.3 - Accrol Group Holdings plc
16th May 202410:08 amRNSForm 8.3 - Accrol Group Holdings Plc
16th May 20248:19 amGNWForm 8.5 (EPT/RI) - Accrol Group Holdings Plc
15th May 20243:13 pmRNSResult of Court Meeting and General Meeting
15th May 202412:08 pmPRNForm 8.3 - Accrol Group Holdings plc
15th May 202410:35 amRNSForm 8.3 - Accrol Group Holdings Plc
15th May 202410:11 amRNSForm 8.3 - Accrol Group Holdings PLC
15th May 20248:08 amGNWForm 8.5 (EPT/RI) - Accrol Group Holdings Plc
14th May 202410:51 amRNSForm 8.3 - Accrol Group Holdings PLC
14th May 202410:16 amRNSForm 8.3 - Accrol Group Holdings Plc
13th May 202410:46 amRNSForm 8.3 - Accrol Group Holdings Plc
10th May 20242:16 pmRNSForm 8.3 - Accrol Group Holdings PLC
10th May 20241:32 pmPRNForm 8.3 - Accrol Group Holdings plc
9th May 202412:58 pmPRNForm 8.3 - Accrol Group Holdings plc
9th May 202410:47 amRNSForm 8.3 - Accrol Group Holdings Plc
9th May 20247:49 amGNWForm 8.5 (EPT/RI) - Accrol Group Holdings Plc
8th May 20245:15 pmRNSTR-1
8th May 20243:04 pmPRNForm 8.3 - Accrol Group Holdings plc
8th May 202412:00 pmRNSForm 8.5 (EPT/RI) - Accrol Group Holdings plc
8th May 202410:57 amRNSForm 8.3 - Accrol Group Holdings Plc
8th May 20248:04 amGNWForm 8.5 (EPT/RI) - Accrol Group Holdings Plc
7th May 20243:27 pmRNSForm 8.3 - Accrol Group Holdings PLC
7th May 20241:11 pmRNSForm 8.3 - ACCROL GROUP HOLDINGS PLC
7th May 202411:13 amGNWForm 8.5 (EPT/RI) - 25.04.2024 AMENDED - Accrol Group Holdings Plc
7th May 20249:18 amRNSForm 8.3 - Accrol Group Holdings Plc
7th May 20248:56 amGNWForm 8.5 (EPT/RI)
3rd May 20243:25 pmRNSForm 8.3 - ACCROL GROUP HOLDINGS PLC
3rd May 20242:42 pmRNSIncreased and Final Offer
3rd May 20241:55 pmPRNForm 8.3 - Accrol Group Holdings Plc
2nd May 20243:25 pmRNSForm 8.3 - ACCROL GROUP HOLDINGS PLC
2nd May 20241:42 pmRNSForm 8.3 - Accrol Group Holdings plc
1st May 20243:25 pmRNSForm 8.3 - ACCROL GROUP HOLDINGS PLC
1st May 20243:11 pmRNSForm 8.3 - ACCROL GROUP HOLDINGS PLC
1st May 202410:05 amRNSForm 8.3 - Accrol Group Holdings Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.